Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial

Endometriosis

Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis

Fertil Steril.

Surrey ES, Soliman AM, Agarwal SK, Snabes MC, Diamond MP

doi: 10.1016/j.fertnstert.

Endometriosis

Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: Analysis of 2 phase III clinical trials

Am J Obstet Gynecol.

Pokrzywinski RM, Soliman AM, Chen J, Snabes MC, Coyne KS, Surrey ES, Taylor HS

doi: 10.1016/j.ajog.2019.11.1255.

Reproductive HealthEndometriosis

Oral contraceptives for pain associated with endometriosis

Cochrane Database Syst Rev.

Brown J, Crawford TJ, Datta S, Prentice A

doi: 10.1002/

Reproductive HealthEndometriosis

Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial

Fertil Steril.

Kaponis A, Chatzopoulos G, Paschopoulos M, Georgiou I, Paraskevaidis V, Zikopoulos K, Tsiveriotis K, Taniguchi F, Adonakis G, Harada T

doi: 10.1016/j.fertnstert.2019.12.018.

Endometriosis

Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study

Hum Reprod.

D'Hooghe T, Fukaya T, Osuga Y, Besuyen R, López B, Holtkamp GM, Miyazaki K, Skillern L

doi: 10.1093/humrep/dez028.

Endometriosis

Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials

Fertil Steril.

Pokrzywinski RM, Soliman AM, Chen J, Snabes M, Diamond MP, Surrey E, Coyne KS

doi: 10.1016/j.fertnstert.

Endometriosis

Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study

Adv Ther.

Heinemann K, Imthurn B, Marions L, Gerlinger C, Becker K, Moehner S, Faustmann T

doi: 10.1007/s12325-020-01331-z.

Endometriosis

Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix

J Sex Med.

Agarwal SK, Soliman AM, Pokrzywinski RM, Snabes MC, Coyne KS

doi: 10.1016/j.jsxm.2020.08.002.

Reproductive Health

Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols

Fertil Steril.

Toftager M, Sylvest R, Schmidt L, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Pinborg A

doi: 10.1016/j.fertnstert.

Related content

Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis

Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: Analysis of 2 phase III clinical trials

Oral contraceptives for pain associated with endometriosis

Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial

Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study

Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials

Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study

Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix

Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols